SIP
NRX

Stoneridge Investment Partners’s NEPHROGENEX INC COM NRX Stock Holding History

Stoneridge Investment Partners’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,125
Closed -$90K – 302
2014
Q3 		$90K Hold
19,125
– – 0.01% 241
2014
Q2 		$116K Sell
19,125
-575
-3% -$3.67K 0.02% 222
2014
Q1 		$160K Buy
+19,700
New +$201K 0.03% 195

Other funds holding NRX

RCP
Rho Capital Partners New York $20.4M AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return

Stoneridge Investment Partners's NRX Position: Q4 2014 in Review

Stoneridge Investment Partners sold out of NEPHROGENEX INC COM (NRX) in Q4 2014, closing a stake of 19,125 shares — an estimated $90K sold.

Stoneridge Investment Partners first reported a position in NRX in Q1 2014 and held it in 3 quarters. The position peaked at $160K in Q1 2014. 14 funds tracked by Wall St. Rank hold NRX as of Q4 2014.

  • Stoneridge Investment Partners reported no remaining NEPHROGENEX INC COM position as of Q4 2014 after selling out during the quarter.
  • Stoneridge Investment Partners sold 19,125 NEPHROGENEX INC COM shares in Q4 2014, an estimated $90K.
  • Stoneridge Investment Partners first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 3 quarters.
  • Stoneridge Investment Partners's NEPHROGENEX INC COM position peaked at $160K in Q1 2014.
  • 14 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q4 2014.

Based on Stoneridge Investment Partners's 13F filing for Q4 2014, filed 26 Jan 2015.